Skip to Content
Skip to Content

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the public consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

spinosad (ISO); Reaction mass of Spinosyn A: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione and Spinosyn D: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2.3.4.6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethy-2,3,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione

EC / List no: 434-300-1 CAS no: 168316-95-8
CLP Annex VI Index number
Further substance information
Spinosyn A: CAS nr 131929-60-7
(2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione

Spinosyn D: CAS nr 131929-63-0
(2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione
Status
Intention
Date of intention
20/02/2018
Expected date of submission
30/11/2022
Submitted for accordance check
Final submission date
Withdrawal date
Legal deadline for opinion adoption
Submitter
Netherlands
Submitter's email
Harmonised classification at the time of the proposal
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Specific concentration limits at the time of the proposal
Proposed harmonised classification by the dossier submitter
Repr. 2, H361f
STOT RE 2, H373
Aquatic Acute 1, M-factor=10
Aquatic Chronic 1, M-factor=1
Proposed specific concentration limits by the dossier submitter
Regulatory programme
Active substance in Plant Protection Products
Active substance in Biocidal Products
Remarks
Active substance spinosad (CAS: 168316-95-8) exists of a mix of two substances; spinosyn A (CAS: 131929-60-7) and spinosyn D (CAS: 131929-63-0)Spinosyn A:
Indexnr 603-209-00-0
H400, H410, M=10

Spinosyn D:
Indexnr 603-209-00-0
H400, H410, M=10
Start of consultation
Deadline for commenting
Hazard classes open for commenting
CLH report
Annexes to the CLH report
Date of opinion
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during public consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
Link to ATP
Latest update
23/09/2019

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1